PPARA and Disorder of energy metabolism: Western blot analysis showed that SMY inhibited the protein expression of HIF1α/PPAR signalling pathway-related proteins to activate the PKA signalling pathway, thereby ameliorating energy metabolism disorder in rats with myocardial hypertrophy.